AASLD The Liver Meeting 2021

Our Attendees Include:

• Adult and pediatric hepatology experts.
• Clinical, basic, and translational researchers.
• Specialists who diagnose and treat liver disease, including gastroenterologists, surgeons, clinical pathologists, anesthesiologists, and radiologists.
• Primary care physicians.
• Nurse practitioners, registered nurses, physician assistants, pharmacists, and other allied health professionals in hepatology and the disciplines listed above.
• Trainees, and students in the disciplines listed above.
• Patient advocates and patients.

Topics : 

– 2021 Academic Debates
– AASLD & AASLD Foundation Awards & Honors Ceremony
– AASLD Distinguished Award
– AASLD_ALEH Joint Symposium
– AASLD_ASGE Endoscopy Course Live Q&A Session
– AASLD_ILTS Transplant Course Live Q&A Session
– Alcohol, Cancer, Fibrosis Cirrhosis Portal Hypertension
– Alcohol, NASH and NAFLD
– Alcohol-associated Liver Disease
– Associates, Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure
– Basic Translational Science, Microbiome Genomics Personalized Medicine
– Basic Science Debrief
– Cancer, Transplant Liver Failure, NASH and NAFLD
– Career Development Workshop
– Cholestatic and Autoimmune Liver Diseases
– Cirrhosis Improving Quality through Patient Empowerment
– Clinical Hepatology Debrief
– Clinical Research Workshop – Part I
– Clinical Research Workshop – Part II
– COVID-19 and the Liver Symposium
– Diversity Workshop
– Emerging Trends Symposium
– Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, Pediatric
– Grit, Grace, Gratitude, and Resilience What You Wish Your Doctors Knew About You
– HBV Cure How Close Are We
– HBV Global Symposium
– Health Outcomes, Fibrosis Cirrhosis Portal Hypertension, TransplantLiver Failure, NASH and NAFLD
– Health Outcomes, Public Health
– Health Outcomes, Training and Career Development, Public Health
– Hepatitis B
– Hepatitis C
– Hepatitis Debrief
– Hepatology Associates
– Hepatotoxicity SIG
– Hyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture
– Leon Schiff State-of-the-Art Lecture
– Liver Cancer
– Liver Cell Biology
– Liver Fibrosis
– Liver Transplantation and Surgery SIG
– Making an Impact Where You Are Patient Voices as a Vehicle for Change
– Microbiome Genomics Personalized Medicine
– NAFLD Debrief
– Nonalcoholic Fatty Liver Disease
– Nutrition 101 for Patients with Chronic Liver Disease
– Panel Discussion Saving More Lives Forward from “A Burden of Genius”
– Parallel 1 Advances with Approved HBV Therapies
– Parallel 2 Health Services and Public Health
– Parallel 3 Metabolic and Genetic Disease Hemochromatosis, Wilsons Disease, Alpha-1 Antitrypsin Deficiency
– Parallel 4 COVID-19 Clinical
– Parallel 5 Pediatric Hepatology Metabolic and Genetic Diseases
– Parallel 6- Experimental and Translational Portal Hypertension and ACLF – The World’s Premier Event in Hepatology
– Parallel 7 Immunosuppression, Outcomes, Complications
– Parallel 8 HBV Cascade of Care, Natural History and Diagnostics
– Parallel 9 COVID-19 Translational and Clinical
– Parallel 10 Diagnostics and Biomarkers of NAFLD
– Parallel 11 Healthcare Quality and Access in Hepatology
– Parallel 12 Donor and Allocation Issues, Living and Split Donor Liver Transplantation
– Parallel 13 Novel HBV Therapies and Approaches
– Parallel 14 Hepatitis C Oral Session
– Parallel 15 Biomarkers and Therapeutics in Autoimmune and Cholestatic Diseases
– Parallel 16 Experimental and Translational Advances in Alcohol-Associated Liver Disease
– Parallel 17 NAFLD and NASH Predicting Outcomes and Response to Interventions
– Parallel 18 Mechanisms of Cholestatic Liver Injury
– Parallel 19 Clinical Advances in Alcohol-Associated Liver Disease
– Parallel 20 Hepatobiliary Neoplasia Clinical Oral Session
– Parallel 21 NAFLD and NASH Clinical Trials of Novel Therapeutics
– Parallel 22 Portal Hypertension Risk Stratification and Treatment for Varices
– Parallel 23 Cell and Molecular Biology
– Parallel 24 Hepatobiliary Neoplasia Experimental Translational Oral Session
– Parallel 25 Portal Hypertension Clinical
– Parallel 26 Liver Fibrogenesis and Non-Parenchymal Cell Biology
– Parallel 27 Diversity, Equity, and Inclusion in Liver Disease Care
– Parallel 28 Gut Liver Axis and Microbiome
– Parallel 29 NAFLD and NASH Management and Outcomes in the Clinic
– Parallel 30- Genomics and Precision Medicine – The World’s Premier Event in Hepatology
– Parallel 31 Clinical Translational Research in Pediatric Hepatology
– Parallel 32 Clinical Acute on Chronic Liver Failure
– Parallel 34 Basic Science Research in Pediatric Hepatology
– Parallel 35 Viral Hepatitis Oral Session (Non-HBV, Non-HCV)
– Parallel 36 Hepatotoxicity
– Patient Annual Forum and Meet & Greet Networking
– Patient Debrief
– Patient Keynote How Physician-Patient Partnerships Can Improve Liver Disease Care & Research
– Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part I Management of Acute-on-Chronic Liver Failure in Adults and Children
– Pediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part II Management of Acute-on-Chronic Liver Failure in Adults and Children
– Pediatric, Cholestatic and Autoimmune Liver Disease
– Portal Hypertension Clinical and Experimental
– Postgraduate Course – Part I
– Postgraduate Course – Part II
– Postgraduate Course – Part III
– Postgraduate Course Live Q&A Session
– Practice Guidelines Debrief for Patients
– Practice Guidelines Workshop
– Presidential Plenary Basic and Translational
– Presidential Plenary Clinical and Translational
– Presidential Plenary Liver Transplant
– Presidential Welcome and President’s Choice Lecture
– Public Health Health Care Delivery
– The Liver Meeting Closing Remarks
– Transplant Surgery Workshop Part I (Increased-risk Organs)
– Transplant Surgery Workshop Part II (Living Donor, Split Liver)
– TransplantLiver Failure, Microbiome Genomics Personalized Medicine
– Viral Hepatitis Elimination Session
– Women’s Health Program

Release Date : November 13-16 2021